These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15591800)

  • 21. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study.
    Tully AM; Roche HM; Doyle R; Fallon C; Bruce I; Lawlor B; Coakley D; Gibney MJ
    Br J Nutr; 2003 Apr; 89(4):483-9. PubMed ID: 12654166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of p53(ser15) and p21/p21(thr145) in peripheral blood lymphocytes as potential Alzheimer's disease biomarkers.
    Tan M; Wang S; Song J; Jia J
    Neurosci Lett; 2012 May; 516(2):226-31. PubMed ID: 22503900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced soluble CD40 ligand and Alzheimer's disease: evidence of a possible pathogenetic role.
    Desideri G; Cipollone F; Necozione S; Marini C; Lechiara MC; Taglieri G; Zuliani G; Fellin R; Mezzetti A; di Orio F; Ferri C
    Neurobiol Aging; 2008 Mar; 29(3):348-56. PubMed ID: 17123665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
    Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
    Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum lipid levels in patients with Alzheimer's disease.
    Presećki P; Mück-Seler D; Mimica N; Pivac N; Mustapić M; Stipcević T; Smalc VF
    Coll Antropol; 2011 Jan; 35 Suppl 1():115-20. PubMed ID: 21648320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A gene expression pattern in blood for the early detection of Alzheimer's disease.
    Booij BB; Lindahl T; Wetterberg P; Skaane NV; Sæbø S; Feten G; Rye PD; Kristiansen LI; Hagen N; Jensen M; Bårdsen K; Winblad B; Sharma P; Lönneborg A
    J Alzheimers Dis; 2011; 23(1):109-19. PubMed ID: 20930264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation between mild cognitive impairment and Alzheimer's disease using the FMLL mini-battery.
    Abizanda P; López-Ramos B; Romero L; Sánchez-Jurado PM; León M; Martín-Sebastiá E; López-Jiménez E
    Dement Geriatr Cogn Disord; 2009; 28(2):179-86. PubMed ID: 19713701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased midkine levels in sera from patients with Alzheimer's disease.
    Salama RH; Muramatsu H; Shimizu E; Hashimoto K; Ohgake S; Watanabe H; Komatsu N; Okamura N; Koike K; Shinoda N; Okada S; Iyo M; Muramatsu T
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):611-6. PubMed ID: 15866365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Japanese version of the Test Your Memory as a screening test in a Japanese memory clinic.
    Hanyu H; Maezono M; Sakurai H; Kume K; Kanetaka H; Iwamoto T
    Psychiatry Res; 2011 Nov; 190(1):145-8. PubMed ID: 21570726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study].
    Wang T; Xiao SF; Li X; Wang Y; Ding B; Ling HW; Chen KM
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):37-40. PubMed ID: 19489242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for Alzheimer's disease among illiterate elderly: accuracy analysis for multiple instruments.
    Aprahamian I; Martinelli JE; Cecato J; Yassuda MS
    J Alzheimers Dis; 2011; 26(2):221-9. PubMed ID: 21593559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels.
    Abdullah L; Paris D; Luis C; Quadros A; Parrish J; Valdes L; Keegan AP; Mathura V; Crawford F; Mullan M
    Neurosci Lett; 2007 Nov; 428(2-3):53-8. PubMed ID: 17964720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Validity of the Spanish version of the Addenbrooke's Cognitive Examination for the diagnosis of dementia and to differentiate Alzheimer's disease and frontotemporal dementia].
    Sarasola D; de Luján-Calcagno M; Sabe L; Crivelli L; Torralva T; Roca M; García-Caballero A; Manes F
    Rev Neurol; 2005 Dec 16-31; 41(12):717-21. PubMed ID: 16355355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem cell factor plasma levels are decreased in Alzheimer's disease patients with fast cognitive decline after one-year follow-up period: the Pythia-study.
    Laske C; Sopova K; Hoffmann N; Stransky E; Hagen K; Fallgatter AJ; Stellos K; Leyhe T
    J Alzheimers Dis; 2011; 26(1):39-45. PubMed ID: 21593573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients.
    Le Bastard N; Leurs J; Blomme W; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2010; 21(1):291-301. PubMed ID: 20421698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the value of plasma BIN1 as a potential biomarker for alzheimer's disease.
    Sun L; Tan MS; Hu N; Yu JT; Tan L
    J Alzheimers Dis; 2013; 37(2):291-5. PubMed ID: 23803295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is increased red cell distribution width (RDW) indicating the inflammation in Alzheimer's disease (AD)?
    Öztürk ZA; Ünal A; Yiğiter R; Yesil Y; Kuyumcu ME; Neyal M; Kepekçi Y
    Arch Gerontol Geriatr; 2013; 56(1):50-4. PubMed ID: 23103090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of TREM2 in peripheral blood of Alzheimer's disease patients.
    Hu N; Tan MS; Yu JT; Sun L; Tan L; Wang YL; Jiang T; Tan L
    J Alzheimers Dis; 2014; 38(3):497-501. PubMed ID: 24002183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The platelet amyloid precursor protein ratio as a diagnostic marker for Alzheimer's disease in Thai patients.
    Srisawat C; Junnu S; Peerapittayamongkol C; Futrakul A; Soi-ampornkul R; Senanarong V; Praditsuwan R; Assantachai P; Neungton N
    J Clin Neurosci; 2013 May; 20(5):644-8. PubMed ID: 23453155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.